News
including downgrading of the TNM stage groupings for localized disease, and splitting of metastatic NPC into IVA and IVB based on the number of metastatic lesions. These revisions would have ...
Hosted on MSN25d
Pembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian CancerAbout 60% had stage IIIA-IIIC disease at screening, and the remaining stage IVA-IVB disease. Half of the patients had a CPS score ≥10. The primary endpoint was PFS in the CPS ≥10 group and in ...
They proved that sequential CRC (chemotherapy-radiotherapy-chemotherapy) was associated with improved survival in women with advanced stage disease compared to other sequencing modalities with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results